{
    "id": "0849",
    "question": "Two weeks after starting chemotherapy with etoposide, a 66-year-old man with small cell lung cancer comes to the physician because of persistent nausea and vomiting. His symptoms improve significantly after the administration of metoclopramide. This patient's symptoms were most likely due to the effect of chemotherapy on which of the following structures?",
    "options": {
        "A": "Vestibular nerve",
        "B": "Intestinal smooth muscle",
        "C": "Vagus nerve",
        "D": "Area postrema"
    },
    "answer": "D",
    "predict": "To answer this question, let's break down the information provided and analyze the situation step by step: 1. **Understanding the context**: The patient is experiencing persistent nausea and vomiting after starting chemotherapy with etoposide for small cell lung cancer. The symptoms improve with the administration of metoclopramide, a dopamine antagonist commonly used to treat nausea and vomiting. 2. **Chemotherapy-induced nausea and vomiting (CINV)**: CINV is a common side effect of chemotherapy, caused by the toxic effects of chemotherapeutic agents on the gastrointestinal (GI) system. The mechanisms of CINV can involve the central nervous system (CNS) and the GI tract itself. 3. **Role of the area postrema**: The area postrema is a circumventricular organ in the brain that is not protected by the blood-brain barrier. It is involved in detecting toxins in the blood and is responsible for vomiting. Chemotherapy can stimulate the area postrema, leading to CINV. Metoclopramide, by blocking dopamine receptors, can also stimulate the area postrema and reduce CINV. 4. **Vestibular nerve (A)**: The vestibular nerve is primarily involved in balance and equilibrium, not directly related to CINV. 5. **Intestinal smooth muscle (B)**: While chemotherapy can affect GI motility, the improvement with metoclopramide suggests that the issue is not primarily with intestinal smooth muscle. 6. **Vagus nerve (C)**: The vagus nerve can be involved in the regulation of GI motility and secretion, but it is not the primary target in this scenario. Considering the above points, the most likely explanation for the patient's symptoms is the stimulation of the area postrema by chemotherapy, which is then alleviated by metoclopramide. ```json { \"step_by_step_thinking\": \"The patient's symptoms of nausea and vomiting improved with metoclopramide, a dopamine antagonist that can stimulate the area postrema. The area postrema is a circumventricular organ that is not protected by the blood-brain barrier and is involved in detecting toxins in the blood, leading to vomiting. Chemotherapy can stimulate the area postrema, causing CINV. Metoclopramide's mechanism of action suggests that the issue is related to the area postrema rather than other options.\", \"answer_choice\": \"D\" } ```",
    "snippets": [],
    "scores": [],
    "execution_time": 56.32687783241272
}